Hogan Men's Desert Boots In Dark Blue Suede Leather Model Number HXM3040W352HG0U805 Blue JuTcHBPOp

Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp
  • Model number: HXM3040W352HG0U805
  • Material: Suede leather
  • Closure: Lace-Up
  • Color: blue
Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp Hogan Men's Desert Boots In Dark Blue Suede Leather - Model Number: HXM3040W352HG0U805 Blue JuTcHBPOp
Follow us on web

Explore Other Industries

Indian pharmaceutical industry supplies over 50 per cent of global demand vaccines.

Latest update: June, 2018

Notes: Source:



Related News

Last Updated: July 03, 2018

Last Updated: June, 2018


India is the largest provider of generic drugs globally. Indian pharmaceutical sector industry supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK.

India enjoys an important position in the global pharmaceuticals sector. The country also has a large pool of scientists and engineers who have the potential to steer the industry ahead to an even higher level. Presently over 80 per cent of the antiretroviral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome) are supplied by Indian pharmaceutical firms.

Market Size

The pharmaceutical sector was valued at US$ 33 billion in 2017. The country’s pharmaceutical industry is expected to expand at a CAGR of 22.4 per cent over 2015–20 to reach US$ 55 billion. India’s pharmaceutical exports stood at US$ 17.27 billion in 2017-18 and are expected to reach US$ 20 billion by 2020.

Indian companies received 304 Abbreviated New Drug Application (ANDA) approvals from the US Food and Drug Administration (USFDA) in 2017. The country accounts for around 30 per cent (by volume) and about 10 per cent (value) in the US$ 70-80 billion US generics market.

India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics is expected grow at an average growth rate of around 30 per cent a year and reach US$ 100 billion by 2025. Biopharma, comprising vaccines, therapeutics and diagnostics, is the largest sub-sector contributing nearly 62 per cent of the total revenues at Rs 12,600 crore (US$ 1.89 billion).


The Union Cabinet has given its nod for the amendment of the existing Foreign Direct Investment (FDI) policy in the pharmaceutical sector in order to allow FDI up to 100 per cent under the automatic route for manufacturing of medical devices subject to certain conditions.

The drugs and pharmaceuticals sector attracted cumulative FDI inflows worth US$ 15.59 billion between April 2000 and December 2017, according to data released by the Department of Industrial Policy and Promotion (DIPP).

Some of the recent developments/investments in the Indian pharmaceutical sector are as follows:

Government Initiatives

Some of the initiatives taken by the government to promote the pharmaceutical sector in India are as follows:

Road Ahead

Medicine spending in India is expected to increase at 9-12 per cent CAGR between 2018-22 to US$ 26-30 billion, driven by increasing consumer spending, rapid urbanisation, and raising healthcare insurance among others.

Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers that are on the rise.

The Indian government has taken many steps to reduce costs and bring down healthcare expenses. Speedy introduction of generic drugs into the market has remained in focus and is expected to benefit the Indian pharmaceutical companies. In addition, the thrust on rural health programmes, lifesaving drugs and preventive vaccines also augurs well for the pharmaceutical companies.

Exchange Rate Used: INR 1 = US$ 0.0155 as on March 30, 2018

Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.



Related News

Last Updated: July 03, 2018

Pharma Clusters
Industry Contacts


Indian pharma company have won around 40 per cent of all Abbreviated New Drug Approval (ANDA) from the US Food and Drug Administration (FDA) between j...

Guess Womens Laylow Sneaker Black/Gold 5NYa5

India Now Magazine

The Luxe Edge - Reshaping India's Lifestyle Choices


KSwiss Women’s Court Pro Ii T CMF Sneaker Rainbow/White LbZyZQm

Fintech, i.e. the technology that enables banking and financial services, is a very fast growing space in India, especially for the start-up domain. Fintechs are offering...

The Indian technology start-up domain is proudly placed at the fourth largest position in the world. The industry was sized at US$ 35 billion in FY18. Last decade saw eme...

Textiles have been one of the oldest and largest industries in India historically, second only to agriculture, and it generates jobs for millions of people. The current e...

Today is the most opportune time for India to revolutionise its science and technology ecosystem. The size of our economy provides the capital, manpower and market to inv...

Daimler India Commercial Vehicle has been able to create a space for its offerings in the already crowded domestic commercial vehicle market. Erich Nesselhauf, MD C...

TUV Rheinland India is a subsidiary of the TUV Rheinland Group, Germany. As part of the India, Middle East, Africa Asia Pacific Group, it caters to the Indian marke...

Netmed.com (India ki pharmacy), is an online portal for medicines where one can upload the prescription, order medicines, and get them delivered at the doorstep. The company came into being in 2015 and since then it is trying to make all the modern medicines available and affordable for all with a hybrid inventory/marketplace model...

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.


Already a member? Login / Retrieve Password

Copyright © 2010-2018 India Brand Equity Foundation

This website uses cookies

URBANARA.co.uk uses cookies to improve your shopping experience. By continuing to use the site, you consent to our use of cookies.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Inactive cookies are cookies that are currently being classified, as well as cookies that have been deactivated, e.g. due to expired or paused marketing campaigns. These cookies are currently not in use.
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Cookie declaration last updated on 15/06/2018 by Cookiebot
Call us for free 0800 77 97 527 | Pieces Ps Ume Suede Boot Blk Coffee Women’s Biker Boots Brown Black Coffee nJ7ZIGk0B

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Shop by Category

Shop by Collection

Spring Summer '18

Shop by Category

Shop by Collection

Last Chance: Living

Shop by Category

Shop by Collection

Carolbar Womens Modern Elegant Lace Up High Heel Platform Ankle Boots Brown T7rq2BHn
> Buying Guide > Polyester


El Naturalista Waraji Women’s Mules Yellow Gelb Yellow FavrB4BBe
NVXIE Womens Ladies Short Low Christmas Boots Delight Sexy Super High Heel Belt Buckle Waterproof Artificial PU Fall Winter Stage Nightclub CRYSTALREDEUR39UK665 p8PPa
Puma Women’s Fierce Lace WNs CrossTrainer Shoe True BlueKnockout Pink Puma Blackpuma White 9DmziXhCs1


Keen Mens NEWPORT Outdoor Sandals Gargoyle/Tawny Olive JkZLUdIKm
Artificial Intelligence
1TO9 Womens Boots ClosedToe Zip AnkleWrap KittenHeel Warm Lining WaterResistant Nubuck Platform RoundToe Urethane Boots MNS02550 Black f0kPe2xjmg
Insun Womens Foldable Slip On Flat Ballet Shoes Black LZO3Jjct
Vans Unisex Adults Classic Slip on Trainers Grey Mono Canvas Asphalt Qd8 cZJzXc8LD
Smart Card Readers
Mustang Women’s 124640421 Loafers Silver Titanium 4mUxbbk4MT


Digital Brand Protection
Security for Financial Institutions
Agodor Womens Flat Lace Up Nubuck Leather Ankle Boots Platform CloseToe Classic Winter Shoes Grey vsszwvP
xyxyx Sandale Women’s Ankle Strap Sandals Pink Copper rpJJ1e
Blauer USA Women’s Wocuptoe Trainers Black Black Ce0njagH7
Secure Connected Cars


Eagsouni® Unisex Barefoot Water Skin Shoes Aqua Socks for Beach Fitness Swim Surf Yoga Exercise Blue xpjWRaNLk
Josef Seibel Mens Klaus Leather Mule Brasil 91l9WELD
Analyst Reports
MODELISA Womens Fashion Sandals Blue wZ2iTVRCk


Route de Pré-Bois 29, P.O. Box 853 CH-1215 Geneva 15, Switzerland Phone: +41 22 594 3000 Fax: +41 22 594 3001 General Information: info@wisekey.com Sales: sales@wisekey.com Technical Support: support@wisekey.com


Copyright © 1999 - 2018 by WISeKey. All Rights Reserved. Repository | Legal disclaimer | Privacy | Terms and Conditions